ATE253364T1 - Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen - Google Patents
Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungenInfo
- Publication number
- ATE253364T1 ATE253364T1 AT99961750T AT99961750T ATE253364T1 AT E253364 T1 ATE253364 T1 AT E253364T1 AT 99961750 T AT99961750 T AT 99961750T AT 99961750 T AT99961750 T AT 99961750T AT E253364 T1 ATE253364 T1 AT E253364T1
- Authority
- AT
- Austria
- Prior art keywords
- olanzapine
- disorder
- oxide
- treatment
- oxides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10955198P | 1998-11-23 | 1998-11-23 | |
PCT/US1999/027644 WO2000030649A1 (en) | 1998-11-23 | 1999-11-22 | Pharmaceutical compositions containing olanzapine-n-oxide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE253364T1 true ATE253364T1 (de) | 2003-11-15 |
Family
ID=22328264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99961750T ATE253364T1 (de) | 1998-11-23 | 1999-11-22 | Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen |
Country Status (9)
Country | Link |
---|---|
US (3) | US6121259A (de) |
EP (1) | EP1135136B1 (de) |
JP (1) | JP2002530340A (de) |
AT (1) | ATE253364T1 (de) |
AU (1) | AU757870B2 (de) |
CA (1) | CA2351719A1 (de) |
DE (1) | DE69912635T2 (de) |
ES (1) | ES2211205T3 (de) |
WO (1) | WO2000030649A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
CA2364211A1 (en) * | 2000-12-05 | 2002-06-05 | Phillip Branch Chappell | Combination treatment for depression, anxiety and psychosis |
TW200402289A (en) * | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
US7973043B2 (en) * | 2002-07-30 | 2011-07-05 | Peter Migaly | Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions |
NZ540054A (en) | 2002-12-27 | 2007-09-28 | Otsuka Pharma Co Ltd | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
AR042806A1 (es) * | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
WO2007137224A2 (en) * | 2006-05-22 | 2007-11-29 | Vanda Pharmaceuticals, Inc. | Method of treatment |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
CN101711236B (zh) * | 2007-04-12 | 2012-10-31 | Nsab神经研究瑞典公司分公司 | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 |
US9018202B2 (en) * | 2010-12-03 | 2015-04-28 | Allergan, Inc. | Methods for treating diseases of the retina |
US9012476B2 (en) | 2011-12-08 | 2015-04-21 | IVAX International GmbH | Hydrobromide salt of pridopidine |
WO2013152105A1 (en) | 2012-04-04 | 2013-10-10 | IVAX International GmbH | Pharmaceutical compositions for combination therapy |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4115568A (en) * | 1974-11-26 | 1978-09-19 | Lilly Industries Limited | Thieno[3,2-b]-[1,5]benzodiazepines |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
US5627178A (en) * | 1991-04-23 | 1997-05-06 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
CA2232559A1 (en) * | 1995-09-29 | 1997-04-03 | Charles Merritt Beasley Jr. | Method for treating a tic disorder |
AU1335397A (en) * | 1995-12-21 | 1997-07-17 | Eli Lilly And Company | Method for treating dermatitis |
AU705834B2 (en) * | 1995-12-22 | 1999-06-03 | Eli Lilly And Company | Method for treating depression |
CN1213966A (zh) * | 1996-03-11 | 1999-04-14 | 伊莱利利公司 | 治疗两极紊乱的方法 |
UA57727C2 (uk) * | 1996-03-11 | 2003-07-15 | Елі Ліллі Енд Компані | Спосіб лікування надмірної агресивності |
DE69733321D1 (de) * | 1996-03-11 | 2005-06-23 | Lilly Co Eli | Olanzapine zur behandlung von drogenmissbrauch |
BR9612552A (pt) * | 1996-03-11 | 1999-07-20 | Lilly Co Eli | Processo para tratamento de autismo |
GB9615767D0 (en) * | 1996-07-26 | 1996-09-04 | Smithkline Beecham Plc | Novel treatment |
-
1999
- 1999-11-22 AT AT99961750T patent/ATE253364T1/de not_active IP Right Cessation
- 1999-11-22 EP EP99961750A patent/EP1135136B1/de not_active Expired - Lifetime
- 1999-11-22 WO PCT/US1999/027644 patent/WO2000030649A1/en active IP Right Grant
- 1999-11-22 DE DE69912635T patent/DE69912635T2/de not_active Expired - Fee Related
- 1999-11-22 US US09/444,159 patent/US6121259A/en not_active Expired - Fee Related
- 1999-11-22 ES ES99961750T patent/ES2211205T3/es not_active Expired - Lifetime
- 1999-11-22 AU AU18266/00A patent/AU757870B2/en not_active Ceased
- 1999-11-22 JP JP2000583532A patent/JP2002530340A/ja active Pending
- 1999-11-22 CA CA002351719A patent/CA2351719A1/en not_active Abandoned
-
2000
- 2000-08-07 US US09/632,584 patent/US6352984B1/en not_active Expired - Fee Related
-
2001
- 2001-10-30 US US10/016,205 patent/US20020065272A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1135136A1 (de) | 2001-09-26 |
AU757870B2 (en) | 2003-03-06 |
DE69912635T2 (de) | 2004-05-13 |
JP2002530340A (ja) | 2002-09-17 |
ES2211205T3 (es) | 2004-07-01 |
EP1135136B1 (de) | 2003-11-05 |
US6121259A (en) | 2000-09-19 |
AU1826600A (en) | 2000-06-13 |
DE69912635D1 (de) | 2003-12-11 |
WO2000030649A1 (en) | 2000-06-02 |
US20020065272A1 (en) | 2002-05-30 |
US6352984B1 (en) | 2002-03-05 |
CA2351719A1 (en) | 2000-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69912635D1 (de) | Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen | |
ATE286398T1 (de) | Desmethylolanzapine enthaltende zusammensetzungen und verfahren | |
BRPI0413022A (pt) | derivados de 3-amino cromado e 2-amino tetralina | |
FI963294A (fi) | Naftyyliamidit keskushermostoaineina | |
DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
BRPI0402420A (pt) | Processos de toner | |
BRPI0416566A (pt) | tratamento de fenilcetonúrias com bh4 | |
DK1253918T3 (da) | Præparater der omfatter modafinil til behandling af forstyrrelse af opmærksomhed og aktivitet ("Attention Deficit Hyperactivity Disorder" ADHD)) | |
DE69917957D1 (de) | Blockcopolymerzusammensetzung für die Modifikation von Asphalt, und Asphaltzusammensetzung enthaltend diese Blockcopolymerzusammensetzung | |
Quoniam et al. | Implicit and explicit emotional memory for melodies in Alzheimer's disease and depression | |
ATE233318T1 (de) | Spezifische oligonukleotide für hepatitis b virus | |
DE60231507D1 (de) | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten | |
PT1047449E (pt) | Composicoes imunologicas e metodos de utilizacao para alterar transitoriamente a mielina do sistema nervoso central mamifero para promover a regeneracao neuronal | |
BRPI0400038A (pt) | Reciclo de condensados excedentes do resfriamento em um processo para purificação de acrilonitrila | |
DE69808119D1 (de) | Diskontinuierliches und kontinuierliches gegenstromstoffaustauschverfahren | |
Brüne | The incidence of akathisia in bipolar affective disorder treated with neuroleptics—a preliminary report | |
Lee et al. | Effects of School Safety Education on Safety Behavior among Elementary School Students. | |
JP2000319390A5 (de) | ||
Laurent | The scent of music | |
BR0305381A (pt) | Composição cosmética, usos de uma composição e processo de lavagem e condicionamento dos cabelos | |
유정 | Narrative Intervention for Older Adults | |
Hirai et al. | Correction to: Comparison of the social responsiveness scale-2 among individuals with Autism Spectrum Disorder and Williams Syndrome in Japan | |
Fountoulakis et al. | Treatment of bipolar disorder: a systematic review of available data | |
Sussman | Helping us to help you better. | |
Beard | Bipolar disorders: Clinical course and outcome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |